ImmuCell Co. (NASDAQ:ICCC) Short Interest Update

ImmuCell Co. (NASDAQ:ICCC) saw a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 23,600 shares, an increase of 490.0% from the October 31st total of 4,000 shares. Approximately 0.4% of the company’s stock are short sold. Based on an average daily trading volume, of 34,600 shares, the days-to-cover ratio is presently 0.7 days.

ImmuCell Stock Performance

ImmuCell stock traded down $0.04 during trading hours on Wednesday, hitting $3.66. 15,102 shares of the stock traded hands, compared to its average volume of 18,976. The firm’s 50 day moving average price is $3.61 and its 200-day moving average price is $3.97. The company has a debt-to-equity ratio of 0.36, a current ratio of 3.11 and a quick ratio of 1.44. The stock has a market capitalization of $32.61 million, a price-to-earnings ratio of -7.40 and a beta of 0.56. ImmuCell has a 1 year low of $3.34 and a 1 year high of $5.59.

ImmuCell Company Profile

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E.